These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10073725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
    Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MR, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F.
    Lancet; 1998 May 23; 351(9115):1540-3. PubMed ID: 10326536
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.
    Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F.
    Clin Exp Immunol; 2003 Nov 23; 134(2):303-8. PubMed ID: 14616791
    [Abstract] [Full Text] [Related]

  • 5. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
    Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F.
    Lancet; 2000 Nov 04; 356(9241):1565-9. PubMed ID: 11075771
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.
    Satti IN, Osman HY, Daifalla NS, Younis SA, Khalil EA, Zijlstra EE, El Hassan AM, Ghalib HW.
    Vaccine; 2001 Feb 28; 19(15-16):2100-6. PubMed ID: 11228382
    [Abstract] [Full Text] [Related]

  • 7. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
    Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM.
    Trans R Soc Trop Med Hyg; 2003 Feb 28; 97(3):365-8. PubMed ID: 15228261
    [Abstract] [Full Text] [Related]

  • 8. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopina M, Hidalgo A, Cevallos W, Correa J.
    Vaccine; 2004 Mar 12; 22(9-10):1320-6. PubMed ID: 15003662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
    Michel MY, Fathy FM, Hegazy EH, Hussein ED, Eissa MM, Said DE.
    J Egypt Soc Parasitol; 2006 Apr 12; 36(1):159-76, following 76. PubMed ID: 16605109
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
    Khalil EA, Elhassan AM, Zijlstra EE, Osman OF, Eljack IA, Ibrahim ME, Mukhtar MM, Ghalib HW, Modabbers F.
    East Afr Med J; 2000 Sep 12; 77(9):468-70. PubMed ID: 12862135
    [Abstract] [Full Text] [Related]

  • 12. Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease.
    Amaral VF, Teva A, Oliveira-Neto MP, Silva AJ, Pereira MS, Cupolillo E, Porrozzi R, Coutinho SG, Pirmez C, Beverley SM, Grimaldi G.
    Mem Inst Oswaldo Cruz; 2002 Oct 12; 97(7):1041-8. PubMed ID: 12471434
    [Abstract] [Full Text] [Related]

  • 13. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production.
    Castés M, Blackwell J, Trujillo D, Formica S, Cabrera M, Zorrilla G, Rodas A, Castellanos PL, Convit J.
    Vaccine; 1994 Aug 12; 12(11):1041-51. PubMed ID: 7975845
    [Abstract] [Full Text] [Related]

  • 14. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers.
    Bahar K, Dowlati Y, Shidani B, Alimohammadian MH, Khamesipour A, Ehsasi S, Hashemi-Fesharki R, Ale-Agha S, Modabber F.
    Clin Dermatol; 1996 Aug 12; 14(5):489-95. PubMed ID: 8889326
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran.
    Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R.
    Vaccine; 2004 Sep 28; 22(29-30):4097-100. PubMed ID: 15364462
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM.
    Clin Exp Immunol; 2005 May 28; 140(2):349-53. PubMed ID: 15807861
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis.
    De Luca PM, Mayrink W, Pinto JA, Coutinho SG, Santiago MA, Toledo VP, Costa CA, Genaro O, Reis AB, Mendonça SC.
    Acta Trop; 2001 Dec 21; 80(3):251-60. PubMed ID: 11700183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.